Probiotic supplements may be considered as an adjunct treatment for glycemic control in women who are pregnant and have gestational diabetes.
Read More »Production Assistant, Diabetes In Control
Gestational Diabetes Effects on Childhood Glucose Metabolism
Children of mothers with untreated gestational diabetes mellitus are at risk of insulin resistance and impairment in glucose metabolism.
Read More »Metformin Safety In Patients With Chronic Kidney Disease And Its Benefits
In patients with stage 3 kidney disease, metformin use may be safe and may reduce the risk of mortality and cardiovascular events.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #168: Molecular Genetics of Type 1 Diabetes Part 5
Linkage studies identify regions of the genome that are shared more frequently than would be expected by chance by relatives affected by a particular disease. Most studies analyze affected sibling pairs and utilize genetic markers that are scattered throughout the genome at moderate density, typically microsatellites. A significant excess of allele sharing identical by-descent (IBD) in affected sibpairs suggests that the region containing the marker locus also contains a disease susceptibility locus. The first linkage scan for T1DM identified 20 chromosomal regions with suggestive evidence of linkage to disease, including the HLA and INS gene regions.
Read More »Association Between Elevated Heart Rate and Type 2 Diabetes
Increased heart rate in people with CAD has shown to increase diagnosis risk despite BMI and blood pressure.
Read More »The ARB Recall: What Really Happened
FDA examines solvent used in production process.
Read More »Long-Term Type 1 Diabetes Associated with Undiagnosed CAD
Higher prevalence of heart disease studied in older people who have type 1.
Read More »7 Minute Workout
The 7 Minute Workout app is the #1 fitness app in 127 countries. Become your own personal trainer to lose weight and get fit with fast, simple daily workouts.
Read More »Consider More Accountability as a Treatment for Some Patients
Male, 57 years of age, type 2 diabetes. He started with us 6 months ago. When he started seeing us, he was taking glipizide 10mg twice a day and metformin 1,000 twice daily for his glucose. His A1C was 7.5%, his BMI was 24. We stopped his glipizide and started him on a SGLT-2 and a weekly GLP-1. He met with the dietitian and made some big dietary changes, at least at the start. He also started wearing a CGM and was in our remote monitoring program. He sent me his CGM readings weekly for 4 months. He was doing so well, we decided he need not send me his weekly numbers but rather we’d review during his visits.
Read More »Diabetes Apps Presentation Part 6
In this week's Homerun Slides, we conclude with a look at the future direction of diabetes apps.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.